Enhanced Anticancer Potential of Pd(II)-Thiosemicarbazone Complexes: Selectivity, Mechanisms, and 3D Models

QR Code

Enhanced Anticancer Potential of Pd(II)-Thiosemicarbazone Complexes: Selectivity, Mechanisms, and 3D Models

<b>Background/Objectives:</b> Cancer remains a major global health challenge, driving the search for novel chemotherapeutic agents. This study aimed to evaluate the structural and biological properties of a series of <b>Pd(II)</b> complexes containing triphenylphosphine and t...

Full description

Saved in:

Bibliographic Details
Main Authors:	Mauro A. Lima, Tamara Teixeira, Dario B. Fortaleza, George B. S. Pereira, Amos O. Akinyemi, Carlos André Ferreira Moraes, Moacir R. Forim, Alzir A. Batista, Jocely L. Dutra, João H. Araujo-Neto, Javier A. Ellena, Fillipe V. Rocha
Format:	Article
Language:	English
Published:	MDPI AG 2025-06-01
Series:	Pharmaceutics
Subjects:	Pd(II) complexes thiosemicarbazones cytotoxicity ovarian cancer
Online Access:	https://www.mdpi.com/1999-4923/17/7/829
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Synthesis of thiosemicarbazone derivatives and evaluation of their cytotoxicity with emphasis on ferroptosis biomarkers; an in vitro study
by: Yasaman Shadmani, et al.
Published: (2025-05-01)

Design and Fabrication of Heterojunctions of Thiosemicarbazones and Metal Oxide Nanoparticles in Search of Their Medicinal Activity
by: Ekhlakh Veg, et al.
Published: (2024-09-01)

Design, synthesis and evaluation of antifungal activity of 8-hydroxyquinolin-5-ylidene thiosemicarbazone derivatives
by: Haonan Zhang, et al.
Published: (2025-01-01)

New Insights into the Anticancer Effects and Toxicogenomic Safety of Two β-Lapachone Derivatives
by: José Rivaldo De Lima, et al.
Published: (2025-06-01)

Enhancing the Catalytic Performance of PdNPs for Cr(VI) Reduction by Increasing Pd(0) Content
by: Hongfei Lai, et al.
Published: (2025-06-01)

Synthesis, cytotoxic screening and molecular docking, DFT calculation of novel furan-heterocyclic derivatives as insecticidal agents
by: Hager G. El-kasabi, et al.
Published: (2025-06-01)

Activity of Negative Regulation of the PD-1/PD-L1/PD-L2 T-Cell Response System in Patients with Pneumonia and Inﬂuenza A (H1N1)
by: A. V. Malyarchikov, et al.
Published: (2021-08-01)

Visualization of PD-L1-positive and PD-1-positive immune cell contact in the breast cancer microenvironment
by: A. Yu. Kalinchuk, et al.
Published: (2024-03-01)

Clinical efficacy and safety of anti-PD-1/PD-L1 treatments in non-small cell lung cancer (NSCLC)
by: Tian Zeng, et al.
Published: (2019-12-01)

Enhancing CAR-T Efficacy: The Role of Anti PD-1/PD-L1 Checkpoint Inhibitors in Modern Cancer Treatment
by: Rishi Kant, et al.
Published: (2025-06-01)

Metabolism of tryptophan in non-small lung cancer patients with different effect of PD-1 / PD-L1 inhibitors immunotherapy
by: E. Yu. Zlatnik, et al.
Published: (2022-06-01)

Clinical observation of the efficacy of PD‐1/PD‐L1 inhibitors in the treatment of patients with advanced solid tumors
by: Miao Wang, et al.
Published: (2021-12-01)

Synthesis and Evaluation of [<sup>18</sup>F]AlF-NOTA-iPD-L1 as a Potential Theranostic Pair for [<sup>177</sup>Lu]Lu-DOTA-iPD-L1
by: Guillermina Ferro-Flores, et al.
Published: (2025-07-01)

Novel 3-Methyl-1,6-Diazaphenothiazine as an Anticancer Agent—Synthesis, Structure, and In Vitro Anticancer Evaluation
by: Beata Morak-Młodawska, et al.
Published: (2025-06-01)

Advances in the structural characterization of complexes of therapeutic antibodies with PD-1 or PD-L1
by: Mengzhen Jiang, et al.
Published: (2023-12-01)

Relationship between the expressions of PD-L1 and tumour-associated fibroblasts in gastric cancer
by: Linsong Mu, et al.
Published: (2019-12-01)

The regulatory effects of PD-1/PD-L1 inhibitors on bone metabolism: opportunities and challenges in osteoporosis management
by: Jia-Wen Wang, et al.
Published: (2025-07-01)

Antifungal Activity of Some New Binuclear Complexes
by: Baghdad Science Journal
Published: (2010-03-01)

Integrating clinical trial landscapes and bibliometric analysis: unveiling the impact of PD-1/PD-L1 inhibitors on renal cell carcinoma research and therapeutic trajectories summary
by: Yuanbin Huang, et al.
Published: (2025-07-01)

Spotlight on nuclear PD-L1 in ovarian cancer chemoresistance: hidden but mighty
by: Meshach Asare-Werehene, et al.
Published: (2025-07-01)

Marine Natural Products as Anticancer Agents 3.0
by: Celso Alves, et al.
Published: (2025-06-01)

ROLE OF PD-L1 ASSESSMENT IN THE ASPECT OF MOLECULAR-GENETIC CLASSIFICATION OF COLORECTAL CANCER. CURRENT STATE OF THE PROBLEM
by: S. V. Vtorushin, et al.
Published: (2021-03-01)

Pd nanowire coatings of laser-treated polyethylene naphthalate: Preparation, characterization and biological response
by: M. Polivkova, et al.
Published: (2018-12-01)

Synthesis, Characterization, and Biological Evaluation of Some 3<i>d</i> Metal Complexes with 2-Benzoylpyridine 4-Allylthiosemicarbazone
by: Vasilii Graur, et al.
Published: (2025-07-01)

<i>PD-L1</i> and <i>PD-L2</i> gene expression in human glioblastoma cells resistant to chemo- and radiotherapy
by: A. A. Pinevich, et al.
Published: (2023-06-01)

Ginseng-Derived Exosomes Attenuate Immune Evasion in NSCLC via PD-L1 Modulation
by: Zhu LJ, et al.
Published: (2025-07-01)

Synthesis and characterization of Pd(II) and Pt(II) complexes containing mixed ligands of thione and diamine
by: Ahmed S. M. Al-Janabi
Published: (2023-02-01)

Lawsonia inermis extract: Antibacterial, anticancer and antioxidant properties
by: S. Revathi, et al.
Published: (2025-04-01)

Mangrove-Derived Fungi as a Reservoir of Bioactive Secondary Metabolites Promising for Anticancer Leads: A Literature Review
by: Ni Kadek Ari Kristiani, et al.
Published: (2023-09-01)

Anticancer Activity of Cerium Oxide Nanoparticles Towards Human Lung Cancer Cells
by: Nithin Krisshna Gunasekaran, et al.
Published: (2025-04-01)

Prognostic significance of PD-L1 expression and evaluation of microsatellite instability status in patients with retroperitoneal leiomyosarcomas
by: V. Е. Bugaev, et al.
Published: (2019-11-01)

Quantum Chemical Calculations for some Isatin Thiosemicarbazones
by: Kandemirli, Fatma, et al.
Published: (2012)

Immunotherapy of cancer tumors with inhibition of PD-1 membrane protein and its ligands interaction
by: A. V. Chetveryakov, et al.
Published: (2021-10-01)

Synthesis, Reductive Reactivity and Anticancer Activity of Cobalt(III)– and Manganese(III)–Salen Complexes
by: Amy Kanina, et al.
Published: (2025-05-01)

A novel thiazole-sulfonamide hybrid molecule as a promising dual tubulin/carbonic anhydrase IX inhibitor with anticancer activity
by: Hussam Elddin Nabeih Khasawneh, et al.
Published: (2025-06-01)

Distinct Roles of HHLA2 and PD-L1 in the Immune Cell and Prognosis of Hepatocellular Carcinoma
by: Wang CH, et al.
Published: (2025-07-01)

An integrative model with HLA‐DR, CD64, and PD‐1 for the diagnostic and prognostic evaluation of sepsis
by: Guosheng Chen, et al.
Published: (2024-01-01)

Pd/Pt IMBALANCE IN LAVAS AND INTRUSIONS OF THE NORILSK-TALNAKH ORE REGION
by: T. V. Dudkin, et al.
Published: (2021-12-01)

Subpopulation composition of PD-L1-positive lymphocytes in the primary tumour in luminal breast cancer patients
by: L. A. Tashireva, et al.
Published: (2024-07-01)

Subpopulations of B lymphocytes in patients with breast cancer depending on the PD-L1 status
by: L. A. Tashireva, et al.
Published: (2023-04-01)